Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.

Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
复制标题

DOI:
10.1111/j.1572-0241.2008.02022.x
复制
发表时间:
2008-09
期刊:
The American journal of gastroenterology
影响因子:
--
通讯作者:
Morales LS
Morales LS
中科院分区:
其他
文献类型:
--
作者:
Flores YN;Yee HF Jr;Leng M;Escarce JJ;Bastani R;Salmerón J;Morales LS

文献摘要

参考文献

被引文献

相似文献

Morbidity and mortality due to liver disease and cirrhosis vary significantly by race/ethnicity in the United States. We examined the prevalence of liver disease risk factors among blacks, Mexican Americans, and whites, including elevated aspartate aminotransferase and alanine aminotransferase activity, infection with viral hepatitis B or hepatitis C, alcohol intake, obesity, diabetes, and metabolic syndrome. Data were obtained from the Fourth National Health and Nutrition Examination Survey (NHANES IV). A logistic regression was used to examine the association of race/ethnicity to liver disease risk factors, controlling for the demographic and socioeconomic variables. Mexican-American men and women are the most likely to have elevated aminotransferase activity. Among men, Mexican Americans are more likely than whites to be heavy/binge drinkers, and blacks are more likely to have hepatitis B or hepatitis C. Among women, Mexican Americans are more likely than whites to be obese and diabetic, and less likely to be heavy/binge drinkers; blacks are more likely than whites to have hepatitis B or hepatitis C, be obese or diabetic, and less likely to be heavy/binge drinkers. In this national sample, the prevalence of risk factors for liver disease varies by race/ethnicity. Mexican Americans and blacks have a greater risk of developing liver disease than their white counterparts. These findings are consistent with the observed racial/ethnic disparities in morbidity and mortality due to chronic liver disease and contribute to the efforts to identify the causes of these disparities. This information can be used by health professionals to tailor screening and intervention programs.
DOI: 10.1002/hep.20466
发表时间: 2004-12-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Browning, JD;Szczepaniak, LS;Hobbs, HH
通讯作者: Hobbs, HH
DOI: 10.3810/pgm.2004.01.1416
发表时间: 2004-01-01
影响因子: 4.2
作者:
Karsan, HA;Rojter, SE;Saab, S
通讯作者: Saab, S
DOI: 10.1016/s0016-5085(99)70506-8
发表时间: 1999-06-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Matteoni, CA;Younossi, ZM;McCullough, AJ
通讯作者: McCullough, AJ
DOI: 10.1097/01.alc.0000133547.70803.83
发表时间: 2004-08-01
影响因子: 3.2
作者:
Hashimoto, E;Taniai, M;Takasaki, K
通讯作者: Takasaki, K
DOI: 10.1016/s0168-8278(99)80381-x
发表时间: 1999-01-01
影响因子: 25.7
作者:
Alter, MJ
通讯作者: Alter, MJ